ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic Achievements • Executed Global Licensing Agreements that could provide up to $292 million in income • Received Cash Milestone Incomes of $116,000 • Achieved Significant Improvements in Earnings •...